Medtronic (FRA:2M6) Cyclically Adjusted PS Ratio: (As of Sep. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2M6 Medtronic PLC FRA:2M6
80 GF Score
Price €79.92
GF Value €86.08
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Medtronic Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medtronic  (FRA:2M6) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medtronic Cyclically Adjusted PS Ratio Related Terms


Medtronic Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Medtronic's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Cyclically Adjusted PS Ratio Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.69 3.74 3.16 3.22 2.94

Medtronic Quarterly Data
Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26 Jul26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.40 3.39 3.86 2.94 0.00

FRA:2M6 vs SYK, BSX, EW: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, Medtronic's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medtronic's Cyclically Adjusted PS Ratio falls into.


FRA:2M6
80GF Score
Medtronic PLC FRA:2M6
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medtronic's Cyclically Adjusted Revenue per Share for the quarter that ended in Jul. 2026 is calculated as:

For example, Medtronic's adjusted Revenue per Share data for the three months ended in Jul. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jul. 2026 (Change)*Current CPI (Jul. 2026)
=6.643/128.7900*128.7900
=6.643

Current CPI (Jul. 2026) = 128.7900.

Medtronic Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201610 4.789 99.776 6.182
201701 4.950 99.178 6.428
201704 5.346 100.773 6.832
201707 4.658 100.673 5.959
201710 4.393 100.374 5.637
201801 4.463 99.377 5.784
201804 4.859 100.374 6.235
201807 4.629 101.470 5.875
201810 4.782 101.271 6.081
201901 4.887 100.075 6.289
201904 5.364 102.068 6.768
201907 4.944 101.969 6.244
201910 5.155 101.969 6.511
202001 5.145 101.371 6.537
202004 4.088 101.969 5.163
202007 4.193 101.570 5.317
202010 4.807 100.474 6.162
202101 4.707 101.171 5.992
202104 5.041 103.065 6.299
202107 4.982 103.763 6.184
202110 4.991 105.557 6.090
202201 5.082 106.255 6.160
202204 5.574 110.242 6.512
202207 5.430 113.262 6.174
202210 5.780 115.315 6.455
202301 5.383 114.470 6.056
202304 5.847 118.213 6.370
202307 5.220 119.903 5.607
202310 5.677 121.111 6.037
202401 5.576 119.179 6.026
202404 6.048 121.232 6.425
202407 5.629 122.560 5.915
202410 5.994 121.956 6.330
202501 6.228 121.473 6.603
202504 6.169 123.888 6.413
202507 5.712 124.613 5.903
202510 5.976 125.410 6.137
202601 5.951 124.690 6.147
202604 6.511 128.430 6.529
202607 6.643 128.790 6.643

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Medtronic (FRA:2M6) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of €79.92 is trading 7.2% below its estimated GF Value™ of €86.08. GuruFocus considers Medtronic to be Fairly Valued.

Key valuation signals for FRA:2M6:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €86.08 vs. price of €79.92 (7.2% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the FRA:2M6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
80GF Score

Get the complete analysis for FRA:2M6

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€79.92
Price
€86.08
GF Value